BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

253 related articles for article (PubMed ID: 31494829)

  • 1. Use of other antimicrobial drugs is associated with trimethoprim resistance in patients with urinary tract infections caused by E. coli.
    Mulder M; Verbon A; Lous J; Goessens W; Stricker BH
    Eur J Clin Microbiol Infect Dis; 2019 Dec; 38(12):2283-2290. PubMed ID: 31494829
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prior antibiotics and risk of antibiotic-resistant community-acquired urinary tract infection: a case-control study.
    Hillier S; Roberts Z; Dunstan F; Butler C; Howard A; Palmer S
    J Antimicrob Chemother; 2007 Jul; 60(1):92-9. PubMed ID: 17540675
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Five-Year Antimicrobial Resistance Patterns of Urinary Escherichia coli at an Australian Tertiary Hospital: Time Series Analyses of Prevalence Data.
    Fasugba O; Mitchell BG; Mnatzaganian G; Das A; Collignon P; Gardner A
    PLoS One; 2016; 11(10):e0164306. PubMed ID: 27711250
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Exploring the relationship between primary care antibiotic prescribing for urinary tract infections, Escherichia coli bacteraemia incidence and antimicrobial resistance: an ecological study.
    Lishman H; Costelloe C; Hopkins S; Johnson AP; Hope R; Guy R; Muller-Pebody B; Holmes A; Aylin P
    Int J Antimicrob Agents; 2018 Dec; 52(6):790-798. PubMed ID: 30145249
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Trimethoprim and ciprofloxacin resistance and prescribing in urinary tract infection associated with Escherichia coli: a multilevel model.
    Vellinga A; Tansey S; Hanahoe B; Bennett K; Murphy AW; Cormican M
    J Antimicrob Chemother; 2012 Oct; 67(10):2523-30. PubMed ID: 22729920
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association between use of different antibiotics and trimethoprim resistance: going beyond the obvious crude association.
    Pouwels KB; Freeman R; Muller-Pebody B; Rooney G; Henderson KL; Robotham JV; Smieszek T
    J Antimicrob Chemother; 2018 Jun; 73(6):1700-1707. PubMed ID: 29394363
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Escherichia coli antimicrobial susceptibility profile and cumulative antibiogram to guide empirical treatment of uncomplicated urinary tract infections in women in the province of Québec, 2010-15.
    Delisle G; Quach C; Domingo MC; Boudreault AA; Gourdeau M; Bernatchez H; Lavallée C
    J Antimicrob Chemother; 2016 Dec; 71(12):3562-3567. PubMed ID: 27494927
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The changing pattern of antimicrobial resistance within 42,033 Escherichia coli isolates from nosocomial, community and urology patient-specific urinary tract infections, Dublin, 1999-2009.
    Cullen IM; Manecksha RP; McCullagh E; Ahmad S; O'Kelly F; Flynn RJ; McDermott T; Murphy P; Grainger R; Fennell JP; Thornhill JA
    BJU Int; 2012 Apr; 109(8):1198-206. PubMed ID: 21883861
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Diet as a risk factor for antimicrobial resistance in community-acquired urinary tract infections in a middle-aged and elderly population: a case-control study.
    Mulder M; Kiefte-de Jong JC; Goessens WHF; de Visser H; Ikram MA; Verbon A; Stricker BH
    Clin Microbiol Infect; 2019 May; 25(5):613-619. PubMed ID: 30099137
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of community-onset healthcare-associated and hospital-acquired urinary infections caused by extended-spectrum beta-lactamase-producing Escherichia coli and antimicrobial activities.
    Saltoglu N; Karali R; Yemisen M; Ozaras R; Balkan II; Mete B; Tabak F; Mert A; Hondur N; Ozturk R
    Int J Clin Pract; 2015 Jul; 69(7):766-70. PubMed ID: 25683907
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prevalence and risk factors for trimethoprim-sulfamethoxazole-resistant Escherichia coli among women with acute uncomplicated urinary tract infection in a developing country.
    Gangcuangco LM; Alejandria M; Henson KE; Alfaraz L; Ata RM; Lopez M; Saniel M
    Int J Infect Dis; 2015 May; 34():55-60. PubMed ID: 25748571
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Plasmid-mediated AmpC beta-lactamase-producing Escherichia coli causing urinary tract infection in the Auckland community likely to be resistant to commonly prescribed antimicrobials.
    Drinkovic D; Morris AJ; Dyet K; Bakker S; Heffernan H
    N Z Med J; 2015 Mar; 128(1410):50-9. PubMed ID: 25829039
    [TBL] [Abstract][Full Text] [Related]  

  • 13. High antimicrobial resistance in urinary tract infections in male outpatients in routine laboratory data, Germany, 2015 to 2020.
    Salm J; Salm F; Arendarski P; Kramer TS
    Euro Surveill; 2022 Jul; 27(30):. PubMed ID: 35904060
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An 11-year analysis of the prevalent uropathogens and the changing pattern of Escherichia coli antibiotic resistance in 38,530 community urinary tract infections, Dublin 1999-2009.
    Cullen IM; Manecksha RP; McCullagh E; Ahmad S; O'Kelly F; Flynn R; McDermott TE; Murphy P; Grainger R; Fennell JP; Thornhill JA
    Ir J Med Sci; 2013 Mar; 182(1):81-9. PubMed ID: 22669684
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antimicrobial susceptibilities of extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae in health care-associated urinary tract infection: focus on susceptibility to fosfomycin.
    Cho YH; Jung SI; Chung HS; Yu HS; Hwang EC; Kim SO; Kang TW; Kwon DD; Park K
    Int Urol Nephrol; 2015 Jul; 47(7):1059-66. PubMed ID: 26026972
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The burden of antimicrobial resistance among urinary tract isolates of Escherichia coli in the United States in 2017.
    Critchley IA; Cotroneo N; Pucci MJ; Mendes R
    PLoS One; 2019; 14(12):e0220265. PubMed ID: 31821338
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Time trend of prevalence and susceptibility to nitrofurantoin of urinary MDR Escherichia coli from outpatients.
    Bruyndonckx R; Latour K; Atud GA; Dubovy P; Jaspers S; Hens N; Catry B; Goossens H; Coenen S
    J Antimicrob Chemother; 2019 Nov; 74(11):3264-3267. PubMed ID: 31377782
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Increased rates of trimethoprim resistance in uncomplicated urinary tract infection: cause for concern?
    Mangin D; Toop L; Chambers S; Ikram R; Harris B
    N Z Med J; 2005 Nov; 118(1225):U1726. PubMed ID: 16286940
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Development of antibacterial resistance: the Dutch experience.
    Beunders AJ
    J Antimicrob Chemother; 1994 May; 33 Suppl A():17-22. PubMed ID: 7928833
    [TBL] [Abstract][Full Text] [Related]  

  • 20. E. coli bacteraemia and antimicrobial resistance following antimicrobial prescribing for urinary tract infection in the community.
    McCowan C; Bakhshi A; McConnachie A; Malcolm W; Barry SJ; Santiago VH; Leanord A
    BMC Infect Dis; 2022 Oct; 22(1):805. PubMed ID: 36307776
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.